Alembic Pharmaceuticals (BOM:533573) Other Operating Expense : ₹36,550 Mil (TTM As of Dec. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Alembic Pharmaceuticals Other Operating Expense?

Alembic Pharmaceuticals's Other Operating Expense for the three months ended in Dec. 2024 was ₹10,630 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₹36,550 Mil.

Alembic Pharmaceuticals's quarterly Other Operating Expense increased from Jun. 2024 (₹9,999 Mil) to Sep. 2024 (₹10,501 Mil) and increased from Sep. 2024 (₹10,501 Mil) to Dec. 2024 (₹10,630 Mil).

Alembic Pharmaceuticals's annual Other Operating Expense increased from Mar. 2022 (₹17,637 Mil) to Mar. 2023 (₹18,101 Mil) and increased from Mar. 2023 (₹18,101 Mil) to Mar. 2024 (₹21,780 Mil).

Alembic Pharmaceuticals Other Operating Expense Historical Data

The historical data trend for Alembic Pharmaceuticals's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alembic Pharmaceuticals Other Operating Expense Chart

Alembic Pharmaceuticals Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Other Operating Expense

Get a 7-Day Free Trial

13,379.50

15,278.20

17,636.70

18,101.10

21,780.40

Alembic Pharmaceuticals Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Operating Expense	Get a 7-Day Free Trial															9,728.90	5,420.40	9,998.50	10,501.10	10,630.20

Alembic Pharmaceuticals Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹36,550 Mil.

Alembic Pharmaceuticals Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Alembic Pharmaceuticals's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Alembic Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alembic Pharmaceuticals Ltd (BOM:533573) » Definitions » Other Operating Expense

Traded in Other Exchanges

APLLTD:India

Address

Alembic Road, Vadodara, GJ, IND, 390 003

Website

https://www.alembicpharmaceuticals.com

Alembic Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company focuses on manufacturing and marketing generic pharmaceutical products across the globe. Alembic also operates a branded formulation business that covers a range of therapeutic areas such as dermatology, oncology, ophthalmology, and injectable formulations. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Alembic Pharmaceuticals Headlines

No Headlines